HealthCo Healthcare & Wellness REIT: Using a Listed Healthcare-Property Platform to Gain Scale in Private Hospital Infrastructure
HealthCo Healthcare & Wellness REIT is another example of how scarce smaller listed private-hospital exposure has become in the public markets. Like Vital, it is not a frontline hospital operator. But it is a listed vehicle with direct and meaningful exposure to private hospitals, and its portfolio has become increasingly shaped by those assets. HealthCo’s FY25 materials describe it as a listed ASX REIT with a mandate across hospitals, aged care, childcare, government, life sciences and primary care, but the defining feature in recent years has clearly been its private-hospital portfolio.
At the broader portfolio level, HealthCo said in its FY25 annual-report and corporate materials that it had a combined portfolio of approximately $1.5 billion, with 26 properties, 99% occupancy and an 11.5-year WALE. Those headline figures already place it in a meaningful position within Australian healthcare real estate, but the sharper point is that the trust’s portfolio is now substantially anchored by hospital infrastructure rather than by lighter-touch healthcare uses alone.
The centrepiece of that exposure is the Healthscope hospital portfolio. HealthCo’s FY25 results presentation says the group and its related structures hold a portfolio of 11 private hospitals in metro locations, representing about 53% of HealthCo’s income and supporting more than 366,000 patient episodes in CY24. That is a very significant level of hospital concentration for a smaller listed healthcare vehicle. It means HealthCo is not merely dabbling in hospital real estate — it has built a major part of its identity around owning the physical infrastructure behind a substantial private-hospital network.
The hospital-portfolio acquisition itself was transformative. In March 2023, HealthCo announced that it had entered into arrangements alongside the Unlisted Healthcare Fund (UHF) to acquire 11 private hospitals leased to Healthscope from Medical Properties Trust for $1.2 billion. HealthCo’s later reporting makes clear that the transaction materially changed the scale, quality and growth outlook of the trust, and it remains the dominant reference point for understanding the group’s current shape. This matters because it explains how a relatively young listed REIT quickly became a relevant name in private-hospital infrastructure.
The economics of that portfolio have also remained a major focus. HealthCo’s FY25 results release said the trust delivered FFO of 6.6 cents per unit, DPU of 4.2 cents, and pro-forma cash and undrawn debt of $103.8 million. At the same time, management said the group was “getting closer to resolving the Healthscope situation,” indicating that the hospital exposure is highly valuable but still operationally and commercially active in terms of management attention. That combination of income generation and active asset management makes the portfolio feel more dynamic than a passive rent book.
What strengthens the profile is that HealthCo has not simply bought a hospital portfolio and stopped. Its materials point to embedded development and expansion opportunities around those assets. The FY25 results presentation referenced brownfield development capex within the Healthscope portfolio, while the broader development pipeline includes projects such as Camden, where HealthCo has described a hospital-anchored health precinct adjacent to a major new public hospital in one of New South Wales’ fastest-growing LGAs. Earlier results also pointed to the successful completion of The George Private Hospital in Camden, which management said was delivered on time and on budget. That sort of pipeline suggests the trust is using hospitals as a platform for wider health-precinct creation, not just as static assets.
There is also clear evidence that the market sees embedded value in the hospital portfolio. HealthCo’s historical and FY25 materials refer to net valuation gains at the Knox Private Hospital and across the broader Healthscope portfolio since acquisition, even while more recent valuation updates acknowledged pressure from the Healthscope backdrop. This is important because it shows both sides of the private-hospital-property equation: these are high-quality, strategically important healthcare assets, but they are still exposed to tenant operating conditions and market sentiment. That tension is part of what makes the trust more editorially interesting than a plain-vanilla property vehicle.
The challenge section, therefore, is unavoidable. HealthCo’s recent materials openly refer to “the Healthscope situation,” and the trust’s FY25 financial performance was also shaped by asset recycling, changes in portfolio composition and unrealised fair-value movements. But those same disclosures show a business still backed by strong occupancy, a long lease profile, a large hospital income base and a development pipeline that management expects to revisit more aggressively once the hospital portfolio issues are stabilised. In other words, the trust is not without complications, but nor is it lacking in underlying strategic relevance.
What makes HealthCo a useful feature for this segment is the visibility of the partner and counterparty ecosystem. Healthscope, UHF, Medical Properties Trust, the developers behind The George Private Hospital, and the broader hospital-anchored precinct pipeline all show a listed group deeply tied to private hospital infrastructure in practical terms. It may not be a hospital operator in the traditional sense, but it is clearly in the business of backing, owning and expanding the physical environments in which private hospital care is delivered. For a smaller public-market name, that is a meaningful and differentiated position.
